OA is a degenerative condition that can originate from a number of causes – injuries, rheumatism, genetic predisposition and more. Yet the result is the same. Cartilage in the knee joint wears away, and without the body's natural cushioning, patients experience pain – often chronic – which restricts their mobility.

+ Johns Hopkins estimates* that by age 40 about 90 percent of the all people have x-ray evidence of OA in weight-bearing joints such as hips and knees, experiencing symptoms mainly later in life.

+ Worldwide figures estimate that 12 percent of the population aged 65 and older suffer from OA of the knee, with 67 percent experiencing medial osteoarthritis.

Quattromed® XP introduces a new treatment option for arthritis patients suffering from medial knee pain, providing an easy-to-use and readily adopted non-invasive approach that can complement other options such as injections, drug therapies and physical conditioning.

+ THE INNOVATIVE DESIGN unloads force on the knee as well or better than any other knee brace on the market, yet Quattromed® XP is dramatically lighter and less bulky, so patients can wear it under everyday clothes and enjoy more active living.

Give your patients every advantage &ndash comfort and performance.
Learn more about Quattromed® XP by reading the information here or by contacting your local Neurotech distributor. Call us on Freephone 1800 511 511 (Rep. of Ireland), LoCall 0845 600 1332 (UK/ N. Ireland) or visit www.neurotechgroup.com for more details.

Click here for detailed information on Quattromed® XP.